British 8.796075
ĠBi 8.630417
otech 0.7575381
Ġplc 2.4170995
's 4.5841947
Ġcancer 6.4767575
Ġdrug 0.9562432
ĠMar 6.955204
im 0.23203264
ast 0.02201151
at 0.0005806733
ĠShows 10.673916
ĠPromise 1.9182621
, 4.241313
ĠBut 1.8650647
ĠFaces 4.5425835
ĠH 3.7116642
urd 0.00501494
les 0.15885632
Ġto 4.9767647
ĠBecome 5.786826
Ġa 1.1139867
ĠBlock 1.389014
buster 0.010361995
Ċ 4.192971
British 1.7107803
ĠBi 0.02018586
otech 0.0010898546
Ġplc 0.52120817
Ġannounced 4.7564244
Ġpromising 3.4804528
Ġresults 0.654719
Ġfor 1.5595285
Ġits 0.23327006
Ġcancer 0.97396004
Ġdrug 0.058871415
, 1.9873388
ĠMar 0.2713701
im 0.0010435284
ast 0.007490446
at 0.00045116857
, 0.41546026
Ġwhich 3.0553203
Ġtargets 3.6541655
Ġthe 1.311679
Ġfast 8.932436
-growing 0.40849864
Ġmatrix 4.705744
Ġmetal 0.10272221
lo 0.006826194
protein 0.18368852
ase 0.9009325
Ġ( 0.8536193
M 0.008946035
MP 0.00052491535
) 0.12625231
Ġmarket 7.585596
. 0.5144343
ĠThe 1.2825801
Ġdrug 1.0658118
Ġis 1.7356153
Ġdesigned 2.5414069
Ġto 0.02564519
Ġinhibit 1.3234878
Ġthe 0.7448794
Ġactivity 1.736736
Ġof 0.017535757
Ġspecific 5.000326
ĠMMP 0.45586765
s 0.42970407
Ġthat 1.6722205
Ġpromote 2.7971625
Ġthe 1.3901074
Ġgrowth 0.8690842
Ġand 1.4098945
Ġspread 0.27174455
Ġof 0.005819302
Ġcancer 0.8092157
Ġcells 1.1681062
. 0.6962039
ĠThe 1.6888976
Ġdrug 1.6598722
Ġis 1.4126383
Ġcurrently 1.3293321
Ġin 0.60412085
ĠPhase 0.56836087
ĠIII 0.3407907
Ġclinical 0.98188716
Ġtrials 0.11974763
, 2.1404152
Ġand 0.87792957
Ġresults 3.2316985
Ġfrom 1.0036634
Ġa 1.5184919
Ġrecent 2.6035292
Ġtrial 1.9678897
Ġdemonstrate 5.005931
Ġthe 2.5901136
Ġdrug 0.57837313
's 0.3760726
Ġpotential 1.8858832
Ġas 2.1322331
Ġa 0.28180256
Ġtherapeutic 4.52952
Ġoption 2.597497
Ġfor 0.30698565
Ġcancer 2.4043334
Ġpatients 0.2374896
.Ċ 4.1499577
Mar 3.2497149
im 0.0016260257
ast 0.00025919382
at 0.0005427849
Ġhas 2.3852677
Ġbeen 1.446006
Ġproven 5.395963
Ġto 0.85460496
Ġbe 1.1589894
Ġeffective 1.3450993
Ġagainst 1.9801059
Ġa 1.4478635
Ġwide 1.5117655
Ġrange 0.5581675
Ġof 0.001151648
Ġcancers 1.1165863
, 0.6128718
Ġincluding 0.30620465
Ġpancreatic 3.2428026
Ġcancer 2.03619
, 0.23867224
Ġcolore 2.168219
ctal 0.00043984794
Ġcancer 0.051278204
, 0.08714653
Ġand 1.1428218
Ġmetast 4.114223
atic 0.124301344
Ġmelan 1.8360565
oma 0.014472571
. 0.20707597
ĠThe 1.2048837
Ġdrug 0.40392694
Ġinhib 3.9453804
its 0.0003902775
Ġthe 0.8624466
Ġactivity 1.270361
Ġof 0.009656929
ĠMMP 0.62520385
s 0.6429992
, 0.76143914
Ġwhich 0.5294726
Ġplay 2.9081068
Ġcritical 5.2545805
Ġroles 0.019468743
Ġin 0.018898876
Ġmany 4.2375727
Ġphysiological 2.2315526
Ġprocesses 0.43278396
, 0.46452853
Ġsuch 1.4939554
Ġas 0.001864976
Ġtissue 1.864416
Ġremodeling 0.9274232
, 0.68497694
Ġwound 1.5200429
Ġhealing 0.11386145
, 0.080807276
Ġand 0.4608568
Ġtumor 3.0034595
Ġinvasion 1.3631607
. 0.72806823
ĠWhen 3.9684353
ĠMMP 0.49920258
s 0.21373926
Ġare 0.29159766
Ġover 0.87190783
activated 3.5666723
, 0.21104296
Ġas 2.6772003
Ġin 1.1999047
Ġcancer 1.033066
, 0.31025925
Ġthey 0.45803583
Ġpromote 2.156598
Ġthe 0.8212976
Ġgrowth 0.6709599
Ġand 0.2955437
Ġspread 0.11248851
Ġof 0.006969094
Ġcancer 0.46609414
Ġcells 0.13515657
Ġby 1.8843027
Ġde 1.1119725
grading 0.00059020595
Ġthe 0.51536196
Ġextr 0.42646608
acellular 0.0011564125
Ġmatrix 0.0145266205
Ġ( 1.3714648
EC 0.100468256
M 0.00040815072
) 1.2348166
Ġsurrounding 1.6142503
Ġthe 0.7530985
Ġtumor 0.53936166
.Ċ 2.4682631
The 1.8161188
ĠPhase 1.9264745
ĠIII 0.2961477
Ġclinical 1.1941283
Ġtrial 0.22742686
Ġconducted 4.313612
Ġby 0.33740473
ĠBritish 0.6497553
ĠBi 0.004097516
otech 0.0017584794
Ġplc 3.2896266
Ġdemonstrated 2.3678293
Ġthat 0.33090082
ĠMar 0.6308052
im 0.000334393
ast 0.00023667533
at 0.00053945085
Ġcan 2.9954276
Ġsignificantly 1.6431621
Ġimprove 2.2245522
Ġthe 0.6737842
Ġprogression 2.929018
-free 0.102287225
Ġsurvival 0.036310896
Ġrate 1.9444398
Ġof 0.5649207
Ġpatients 0.92498404
Ġwith 0.25758958
Ġadvanced 1.0366443
Ġpancreatic 0.89198166
Ġcancer 0.029920802
. 0.36885276
ĠIn 2.3410363
Ġthe 0.9564622
Ġtrial 0.660833
, 0.025827944
Ġpatients 1.322792
Ġwho 1.901481
Ġreceived 0.74186593
ĠMar 0.6690474
im 0.00050072797
ast 0.00037657277
at 0.00033200893
Ġhad 1.5465188
Ġa 0.3040517
Ġmedian 0.829505
Ġprogression 0.29336852
-free 0.012336932
Ġsurvival 0.007205248
Ġrate 1.1368552
Ġof 0.032581136
Ġ 0.12571388
2 1.9616792
. 0.016147802
3 2.540608
Ġmonths 0.008996007
, 0.40640485
Ġcompared 0.38986662
Ġto 0.40828753
Ġ 0.39292488
1 0.12599927
. 0.014481383
6 2.0094905
Ġmonths 0.00702415
Ġfor 0.33691955
Ġpatients 0.5363185
Ġwho 0.3551412
Ġreceived 0.32562512
Ġthe 1.4822143
Ġplacebo 1.0061505
. 0.25986814
ĠThe 1.1140704
Ġdrug 1.3324801
Ġshowed 4.725563
Ġsimilar 2.0634825
Ġpromising 3.7490554
Ġresults 0.11981753
Ġin 0.44260746
Ġthe 2.569604
Ġtreatment 0.5601559
Ġof 0.005674222
Ġother 2.5945535
Ġcancers 0.8079719
Ġas 2.42217
Ġwell 0.0046985457
.Ċ 0.8957261
However 2.8938184
, 0.0012279659
Ġdespite 2.5130777
ĠMar 2.597288
im 0.0005804349
ast 0.0006613265
at 0.0019666972
's 0.018901914
Ġpotential 1.6915886
Ġto 2.0716898
Ġbecome 0.6509624
Ġa 0.075573735
Ġblockbuster 0.14448467
Ġdrug 0.45024967
, 0.121813536
Ġthere 2.3625588
Ġare 0.08820085
Ġsignificant 3.6352024
Ġhurdles 0.58953404
Ġthat 0.8083328
ĠBritish 2.584012
ĠBi 0.0032818099
otech 0.0010011323
Ġplc 0.555294
Ġwill 1.2803922
Ġhave 0.33804306
Ġto 0.0012707087
Ġovercome 0.11364621
. 2.04867
ĠFirstly 4.9631596
, 0.001415235
Ġthe 0.67816865
Ġdrug 0.5564807
's 1.6066692
Ġpatent 3.8130744
Ġprotection 1.0507407
Ġhas 2.5181391
Ġexpired 0.903362
, 0.5490292
Ġwhich 1.42978
Ġmeans 0.7073167
Ġthat 0.3294268
Ġthe 1.9620383
Ġdrug 0.681151
Ġis 1.7970252
Ġnow 1.4295256
Ġavailable 1.8205972
Ġas 1.854495
Ġa 0.10086763
Ġgeneric 0.040729236
Ġdrug 1.9406947
. 0.5954882
ĠThis 2.4261935
Ġwill 1.6722261
Ġmake 2.0313618
Ġit 0.33161628
Ġdifficult 0.48636237
Ġfor 0.09300121
ĠBritish 0.2745573
ĠBi 0.0026127594
otech 0.00013691289
Ġplc 0.11203779
Ġto 0.013899615
Ġgenerate 2.6075435
Ġsignificant 1.6521566
Ġrevenue 1.2969193
Ġfrom 0.18111415
Ġthe 0.6169709
Ġdrug 0.25831312
.Ċ 1.7752085
Second 0.36690533
ly 0.019104851
, 0.0008790658
Ġthe 0.8795558
Ġcompany 3.0876472
Ġwill 1.4636048
Ġneed 2.5599325
Ġto 0.05317813
Ġdemonstrate 3.191044
Ġthe 1.2418842
Ġdrug 0.64547634
's 0.005570491
Ġsafety 1.7726443
Ġand 0.50876343
Ġefficacy 0.25921738
Ġthrough 3.3984993
Ġfurther 2.1642685
Ġclinical 0.15526068
Ġtrials 0.053603165
. 0.55262065
ĠWhile 3.710609
Ġthe 0.42622244
Ġresults 2.0220728
Ġfrom 0.5950005
Ġthe 0.117860906
ĠPhase 0.2998816
ĠIII 0.018587084
Ġclinical 0.3344042
Ġtrial 0.13626121
Ġare 1.1017015
Ġpromising 0.30322757
, 0.008015179
Ġthey 2.00929
Ġwill 3.5917063
Ġneed 0.81574875
Ġto 0.030144067
Ġbe 0.07632019
Ġreplicated 1.4177583
Ġin 0.35539985
Ġlarger 2.1897612
-scale 2.9217405
Ġtrials 0.91977227
Ġto 1.5028886
Ġensure 1.5720397
Ġthat 0.4956675
Ġthe 0.25619557
Ġdrug 0.23722896
Ġis 0.53094393
Ġsafe 0.53043514
Ġand 0.39184365
Ġeffective 0.062402774
Ġfor 0.9270282
Ġa 2.6398208
Ġwider 1.2330583
Ġrange 0.66906863
Ġof 0.0006220113
Ġpatients 0.43150726
.Ċ 0.5901553
Third 1.4508371
ly 0.012418763
, 0.0021152855
ĠMar 2.1981752
im 0.0003088871
ast 0.0004071971
at 0.00049798633
Ġfaces 2.3656693
Ġcompetition 0.67994654
Ġfrom 0.04672027
Ġother 0.5979537
ĠMMP 0.8751227
Ġinhibitors 0.21853955
Ġcurrently 2.5834432
Ġin 0.3643469
Ġdevelopment 0.9564834
. 0.46133512
ĠSeveral 3.7140915
Ġother 1.5851046
Ġpharmaceutical 1.5291715
Ġcompanies 0.032308906
Ġare 0.761005
Ġdeveloping 1.1006187
ĠMMP 0.83404666
Ġinhibitors 0.043422177
Ġto 2.6357834
Ġtarget 1.9207823
Ġcancer 2.378543
, 1.0657938
Ġsuch 2.0454564
Ġas 0.0020832857
ĠGl 4.2364073
ax 0.008622136
o 0.0058376724
Smith 0.08134921
K 0.0041377684
line 0.005028456
Ġplc 0.37007135
's 0.9832578
ĠB 4.3707213
MS 1.9279506
- 0.36675772
275 0.058850173
291 0.21992446
Ġand 0.9109569
ĠMillennium 4.552953
ĠPharmaceuticals 0.04819916
ĠInc 0.9592185
.' 0.18657188
s 0.0013039262
Ġ( 5.231189
now 2.6698012
ĠT 1.8269566
aked 0.007187019
a 0.00036930136
ĠPharmaceutical 0.7455796
ĠCo 0.3092242
. 0.5316792
ĠLtd 0.018053949
.) 0.66865575
ĠPr 6.686545
in 1.593973
om 0.051324982
ast 0.002223176
at 0.00044961896
. 0.48337942
ĠThis 3.0852373
Ġmeans 1.7243104
Ġthat 0.026300417
ĠBritish 0.49727523
ĠBi 0.0035764305
otech 0.00018482542
Ġplc 0.034650654
Ġwill 0.162484
Ġneed 1.1134509
Ġto 0.008132009
Ġwork 3.5992203
Ġhard 0.5986644
Ġto 0.037770502
Ġdifferentiate 1.3312279
ĠMar 0.68042654
im 0.00031329764
ast 0.00015490896
at 0.00022380134
Ġfrom 0.24334683
Ġits 0.897876
Ġcompetitors 0.08140603
Ġand 2.04503
Ġposition 3.7260714
Ġit 0.7253181
Ġas 0.0483098
Ġthe 1.0250983
Ġmost 2.022286
Ġeffective 0.59536207
ĠMMP 0.47417408
Ġinhibitor 0.014744059
.Ċ 1.912219
British 2.9546928
ĠBi 0.004018211
otech 0.0012746387
Ġplc 0.036620196
Ġwill 2.2454705
Ġneed 1.0552601
Ġto 0.016996553
Ġinvest 4.628628
Ġin 2.4945967
Ġmarketing 3.0360074
Ġand 0.7365742
Ġresearch 4.6439476
Ġand 0.6945705
Ġdevelopment 0.010436323
Ġto 0.7078616
Ġensure 1.3091902
Ġthat 0.27544093
ĠMar 0.33825764
im 0.00018840152
ast 0.00012213163
at 0.000418637
Ġbecomes 1.3528644
Ġa 0.10243712
Ġblockbuster 0.4710073
Ġdrug 0.13023102
. 0.3099285
ĠThe 1.0563159
Ġcompany 0.2226295
Ġwill 0.5375558
Ġneed 0.7851373
Ġto 0.017593265
Ġconduct 2.189589
Ġfurther 0.8915346
Ġtrials 2.7273772
Ġto 0.25502926
Ġdemonstrate 1.0688173
Ġthe 0.25208873
Ġdrug 0.18361382
's 0.0035594464
Ġsafety 0.32821473
Ġand 0.024646128
Ġefficacy 0.094583794
Ġand 2.0954452
Ġto 1.8695503
Ġdetermine 4.0697217
Ġthe 0.54590017
Ġoptimal 1.3288426
Ġdose 1.545709
Ġand 1.3368042
Ġtreatment 2.0344265
Ġfor 6.1509123
Ġeach 2.8612473
Ġcancer 1.4944003
Ġtype 0.7050687
. 0.08950446
ĠAdditionally 3.565646
, 0.0010335227
Ġthe 0.9091053
Ġcompany 0.038220037
Ġwill 0.11172355
Ġneed 0.13276847
Ġto 0.007858585
Ġdevelop 2.4300652
Ġstrong 3.8089347
Ġpartnerships 2.5361402
Ġwith 0.1321991
Ġphysicians 3.9050841
, 1.8110538
Ġhospitals 1.5285977
, 0.0220367
Ġand 0.1374044
Ġother 1.415953
Ġstakeholders 2.41891
Ġto 0.5336837
Ġensure 1.2961898
Ġthat 0.30124238
ĠMar 1.2967122
im 0.0001657565
ast 0.00012118533
at 0.0002585978
Ġis 0.6501227
Ġwidely 1.5187984
Ġprescribed 2.2802515
Ġand 1.2895433
Ġused 1.3209265
Ġin 2.433958
Ġthe 1.3566331
Ġtreatment 0.70315087
Ġof 0.0077119195
Ġcancer 0.24957235
.Ċ 1.1084769
Despite 2.9110518
Ġthe 0.8909607
Ġchallenges 1.0587473
, 1.4734477
ĠMar 0.7953941
im 0.00022797346
ast 0.0004967943
at 9.3291674e-05
's 2.5600595
Ġpotential 1.0607401
Ġto 0.9050376
Ġbecome 0.3661123
Ġa 0.01753634
Ġblockbuster 0.03738771
Ġdrug 0.075842835
Ġis 0.73153687
Ġsignificant 2.3420691
. 0.24016523
ĠThe 1.0446007
Ġdrug 0.2961001
Ġhas 1.2975734
Ġdemonstrated 2.2668867
Ġpromising 1.329735
Ġresults 0.088743895
Ġin 0.29303178
ĠPhase 2.3833551
ĠIII 0.13014238
Ġclinical 0.16101617
Ġtrials 0.0078012147
Ġand 1.5095196
Ġhas 0.9672238
Ġthe 1.1092424
Ġpotential 0.05247988
Ġto 0.0059289164
Ġbecome 1.9602381
Ġa 0.5752361
Ġvaluable 4.051803
Ġtherapeutic 0.72124684
Ġoption 0.053122062
Ġfor 0.12071144
Ġcancer 0.66902983
Ġpatients 0.02031214
. 0.40301868
ĠBritish 1.3814354
ĠBi 0.0025680452
otech 0.0002134343
Ġplc 0.024384513
Ġmust 3.1881058
Ġwork 1.3505093
Ġhard 0.12105876
Ġto 0.026793322
Ġovercome 1.1397514
Ġthe 0.2692172
Ġhurdles 0.68331003
Ġand 1.5692035
Ġposition 2.1525702
ĠMar 0.24365044
im 0.00021200384
ast 0.00018399098
at 0.00028982185
Ġas 0.041323867
Ġthe 0.320801
Ġmost 0.66889936
Ġeffective 0.03492709
ĠMMP 0.11298288
Ġinhibitor 0.0059998943
Ġon 1.3166698
Ġthe 0.00045998234
Ġmarket 0.002204736
. 1.2973502
ĠWith 3.8775535
Ġthe 1.1792784
Ġright 0.26040494
Ġinvestment 3.0858002
Ġand 0.59853536
Ġstrategy 1.8973501
, 0.014407821
ĠMar 0.5026823
im 0.00020151392
ast 0.0002005603
at 7.1238996e-05
Ġcould 1.4419802
Ġbecome 0.31123692
Ġa 0.21238647
Ġkey 4.9562716
Ġplayer 1.7653328
Ġin 0.013347392
Ġthe 0.09066125
Ġfight 4.1912084
Ġagainst 0.00825498
Ġcancer 0.0063149394
. 1.2881732
